War in Ukraine may require significant trial changes, EMA says in new guidance
As the war in Ukraine rages on, the European Medicines Agency is looking to help sponsors of ongoing clinical trials navigate the disruptions that are …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
